Proteolysis-targeting chimeras (PROTACs) enable the selective and sub-stoichiometric elimination of pathological proteins, yet only two E3 ligases are routinely used for this purpose. Here, we expand the repertoire of PROTAC-compatible E3 ligases by identifying a novel small molecule scaffold targeting the ubiquitin E3 ligase KLHDC2 using a fluorescence polarization-based high-throughput screen. We highlight the utility of this ligand with the synthesis of PROTACs capable of potently degrading BRD4 in cells. This work affords additional chemical matter for targeting KLHDC2 and suggests a practical approach for identifying novel E3 binders by high-throughput screening.
Targeted protein degradation by KLHDC2 ligands identified by high-throughput screening.
通过高通量筛选鉴定出KLHDC2配体对蛋白质的靶向降解作用
阅读:5
作者:Zhou Han, Zhou Tonglian, Yu Wenli, Liu Liping, Ko Yeonjin, Johnson Kristen A, Wilson Ian A, Schultz Peter G, Bollong Michael J
| 期刊: | Elife | 影响因子: | 6.400 |
| 时间: | 2025 | 起止号: | 2025 Jun 16; 14:RP106844 |
| doi: | 10.7554/eLife.106844 | 研究方向: | 免疫/内分泌 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
